Modified Radical Prostatectomy for Prostate Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial will evaluate whether the following aspect of surgical technique influence outcome: Lymph node dissection. In some patients, scans taken before surgery show that a lymph node has cancer. Surgeons make sure to remove those affect lymph nodes and all other lymph nodes in the area. However, it is not known whether removing lymph nodes helps prostate cancer patients whose scans do not show positive nodes. In this study, patients with clear scans will either receive a lymph node dissection or not."
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
Is modified radical prostatectomy with pelvic lymph node dissection safe for humans?
The research articles focus on the practice and outcomes of radical prostatectomy with pelvic lymph node dissection for prostate cancer, but they do not provide specific safety data. However, this procedure is a standard treatment for high-risk prostate cancer, suggesting it is generally considered safe when performed by experienced surgeons.12345
How does the lymph node template treatment differ from other prostate cancer treatments?
The lymph node template treatment during a modified radical prostatectomy for prostate cancer involves a specific approach to removing lymph nodes, which can be either limited or extended. This method is unique because it focuses on the diagnostic and therapeutic benefits of lymph node dissection, potentially impacting cancer-specific survival by addressing the burden of positive nodes rather than just the number of nodes removed.678910
What data supports the effectiveness of the treatment Lymph node template in the clinical trial Modified Radical Prostatectomy for Prostate Cancer?
Who Is on the Research Team?
Andrew Vickers, PhD
Principal Investigator
Memorial Sloan Kettering Cancer Center
Are You a Good Fit for This Trial?
This trial is for men aged 21 or older with prostate cancer who are scheduled for radical prostatectomy at MSKCC. It's open to those without positive lymph nodes on scans and no prior pelvic radiation therapy. The study includes patients regardless of whether they're eligible for both surgical modifications being tested.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Surgery
Participants undergo radical prostatectomy with or without lymph node dissection
Post-operative Monitoring
Participants are monitored for urinary tract infection within 10 days of catheter removal
Follow-up
Participants are monitored for patient-reported hernia and biochemical recurrence
What Are the Treatments Tested in This Trial?
Interventions
- Lymph node template
Find a Clinic Near You
Who Is Running the Clinical Trial?
Memorial Sloan Kettering Cancer Center
Lead Sponsor